Page last updated: 2024-10-21

3-methylcholanthrene and Medulloblastoma

3-methylcholanthrene has been researched along with Medulloblastoma in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Medulloblastoma: A malignant neoplasm that may be classified either as a glioma or as a primitive neuroectodermal tumor of childhood (see NEUROECTODERMAL TUMOR, PRIMITIVE). The tumor occurs most frequently in the first decade of life with the most typical location being the cerebellar vermis. Histologic features include a high degree of cellularity, frequent mitotic figures, and a tendency for the cells to organize into sheets or form rosettes. Medulloblastoma have a high propensity to spread throughout the craniospinal intradural axis. (From DeVita et al., Cancer: Principles and Practice of Oncology, 5th ed, pp2060-1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zimmerman, HM1

Other Studies

1 other study available for 3-methylcholanthrene and Medulloblastoma

ArticleYear
The histopathology of experimental "medulloblastoma".
    Acta neuropathologica, 1967, Mar-06, Volume: 8, Issue:1

    Topics: Animals; Carcinogens; Cerebellar Neoplasms; Cerebellum; Endoplasmic Reticulum; Medulloblastoma; Meth

1967